# A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases

> **NCT01260415** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 11 (actual)

## Conditions studied

- Colorectal Cancer
- Liver Metastases

## Interventions

- **DRUG:** Panitumumab, Oxaliplatin, 5-FU

## Key facts

- **NCT ID:** NCT01260415
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260415, "A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01260415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*